The FDA is currently reviewing concerns regarding mail-order abortion pills and the circulation of mifepristone.
5 reports, 4 independent
Updated Sep 21
Gone quiet
- Reports
- 5
- Developments
- 5
- Repetition
- 20%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA is currently reviewing concerns regarding mail-order abortion pills and the circulation of mifepristone.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA relaxes mifepristone dispensing rules; DOJ refuses to enforce mail-in bans.1 source
The FDA has approved the mail-order prescribing of abortion pills.1 source
- The FDA is facing scrutiny regarding mifepristone safety after study findings prompted the Trump administration to launch an investigation into drug safety.Sub-event
FDA is reviewing mail-order abortion pills and concerns over mifepristone circulation.1 source
FDA regulates mifepristone amid federal vs. state law conflict.1 source
Keep exploring
The entities involved
- FDA
-
United States of America
vocal track by Kikki Danielsson; 1980 studio recording
Related events
- The FDA is facing actions seeking to revoke mifepristone's approval, challenging the mail-order policy, and pausing related lawsuits.
- FDA enabled a mail-order abortion scheme while Joe Biden challenged the Supreme Court decision and Planned Parenthood secured record funding.
- Bills are being pushed through Congress, with the involvement of Josh Hawley, to restrict access to abortion pills and debate the scope of drug approval and safety studies.